What is qof points

The results for previous years are presented in the chart, which also displays the year's Clinical Commissioning Group CCG and England averages.

Similar charts are available for the total achievement results, the individual domain results and the underlying achievement details for the individual indicators within each indicator group. You can use this specially designed website to make specific searches on achievement for years prior to in the following ways:.

For the reporting year, this functionality is restricted to disease prevalence only. The majority of QOF indicators were income protected i. These changes mean that indicator data may be inaccurate for the reporting year, and comparisons with data from previous years would be misleading.

Therefore, for the reporting year, this website includes prevalence data only; they are available in the. General enquiries enquiries nhsdigital. Press office only media nhsdigital. Understanding the results. Clinical Prevalence:. Clinical Domain Indicator Groups:. Understanding the results Example of the results What this site can tell you What this site cannot tell you.

Location: England Wales Northern Ireland. Audience: GPs Practice managers. Updated: Monday 18 January Find the latest changes to the quality and outcomes framework QOF or equivalent by nation.

Changes from April 97 points were recycled into 11 more appropriate indicators. Changes to existing domains A number of changes have been made to the asthma, COPD and heart failure domains, including: Asthma A requirement to establish and maintain a register of patients aged six years and over with a diagnosis of asthma, in line with NICE guidance. The use of a minimum of two diagnostic tests to confirm an asthma diagnosis. The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the practice receiving confirmation of the diagnosis.

The contractor establishes and maintains a register of patients aged 18 years or over with CKD with classification of categories G3a to G5 previously stage 3 to 5. The percentage of patients on the CKD register who have hypertension and proteinuria and who are currently being treated with an angiotensin-receptor blocker or an angiotensin-converting enzyme inhibitor.

The percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio or protein:creatinine ratio test in the preceding 12 months. The percentage of patients with COPD and Medical Research Council MRC Dyspnoea Scale of 3 or more at any time in the preceding 15 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme. The percentage of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received information from the contractor about long acting reversible methods of contraception in the preceding 12 months.

The percentage of patients with coronary heart disease who have had influenza immunisation in the preceding 1 August to 31 March. The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken. The percentage of patients diagnosed with dementia whose care plan has been reviewed in a face-to-face review in the preceding 12 months.

The percentage of patients with dementia with the contact details of a named carer on their record. The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have been reviewed within days of the date of diagnosis. The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have had a bio-psychosocial assessment by the point of diagnosis.